Table of Contents
- Executive Summary: 2025 Key Insights & Market Outlook
- Global Market Size & Forecasts Through 2030
- Emerging Technologies Revolutionizing Aflatoxin Detection
- Major Facility Expansions and New Entrants
- Regulatory Developments: 2025 and Beyond
- Competitive Landscape: Leading Companies & Innovations
- Application Trends: Food, Feed, and Agricultural Sectors
- Supply Chain Challenges & Solutions
- Sustainability and Automation in Facility Operations
- Future Outlook: Opportunities and Strategic Recommendations
- Sources & References
Executive Summary: 2025 Key Insights & Market Outlook
In 2025, aflatoxin analysis facilities are positioned at the forefront of global food safety initiatives, responding to heightened regulatory scrutiny and increasing demand for rapid, accurate detection of mycotoxins in food and feed products. The market is witnessing significant investments in laboratory infrastructure, analytical instrumentation, and digital integration, driven by both public health imperatives and international trade requirements.
Aflatoxin contamination, predominantly impacting grains, nuts, and dairy products, remains a critical concern worldwide. In 2025, regulatory agencies such as the European Union and the United States Food and Drug Administration (FDA) have maintained or tightened permissible aflatoxin limits, compelling facilities to adopt state-of-the-art testing standards. This has led to a marked increase in the deployment of high-throughput liquid chromatography, immunoassay kits, and mass spectrometry platforms. Leading suppliers such as Agilent Technologies, PerkinElmer, and Eurofins Scientific have reported rising demand for their aflatoxin testing solutions, with new product launches in 2024-2025 featuring enhanced sensitivity, automation, and cloud-based data management.
Emerging economies, particularly in Asia and Africa, are scaling up their aflatoxin analysis capabilities to meet export standards and mitigate domestic health risks. Regional laboratories are increasingly partnering with global instrument manufacturers for technology transfer and training. For instance, Neogen Corporation has expanded its suite of rapid lateral flow and ELISA-based aflatoxin tests tailored to resource-limited settings. Similarly, Romer Labs has launched mobile testing solutions aimed at field sampling and on-site analysis, facilitating faster decision-making in the supply chain.
Looking ahead, the aflatoxin analysis sector is expected to experience moderate but sustained growth through 2027, underpinned by ongoing regulatory evolution and the increasing prevalence of climate events that exacerbate mycotoxin contamination. Investments in digitalization—such as laboratory information management systems (LIMS) and remote calibration—are anticipated to further enhance throughput and traceability. Strategic collaborations between food producers, reference laboratories, and technology providers are projected to accelerate, fostering innovation in analytical methods and standardization across markets. In summary, aflatoxin analysis facilities in 2025 are characterized by advanced technology adoption, global network expansion, and a proactive stance toward safeguarding food safety in a changing risk landscape.
Global Market Size & Forecasts Through 2030
The global landscape for aflatoxin analysis facilities has experienced significant growth as concerns over food safety and regulatory compliance continue to intensify. As of 2025, the demand for reliable and precise aflatoxin detection has spurred investments in advanced laboratory infrastructure in both established and emerging economies. Key drivers include stricter regulatory frameworks imposed by authorities such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA), which mandate rigorous testing protocols for a wide range of agricultural commodities, notably grains, nuts, and dairy products.
Major players in the development and supply of aflatoxin analysis technologies, such as Eurofins Scientific, Neogen Corporation, and R-Biopharm AG, have expanded their global networks of accredited testing facilities. These organizations have reported increased throughput and the integration of rapid screening solutions, such as lateral flow devices and ELISA kits, into their service offerings. For example, Eurofins Scientific operates a network of ISO 17025-accredited laboratories worldwide, performing advanced mycotoxin analysis using HPLC, LC-MS/MS, and immunoassay-based methods.
Looking to the period through 2030, industry projections suggest continued expansion of aflatoxin analysis capacities, particularly in Asia-Pacific and Africa, where heightened awareness of foodborne risks and export requirements are driving infrastructure upgrades. Multinational instrument manufacturers like Agilent Technologies and Waters Corporation are actively collaborating with both public and private sector laboratories to deploy advanced analytical platforms and training services.
The sector is also witnessing a trend toward decentralized rapid testing at critical points in the supply chain, enabled by portable technologies provided by companies such as Neogen Corporation and R-Biopharm AG. This shift is expected to complement centralized laboratory facilities, improving overall testing coverage and turnaround times. The continued rollout of digital laboratory information management systems (LIMS) and data integration capabilities will further enhance the scalability and efficiency of aflatoxin analysis operations globally.
In summary, the global market for aflatoxin analysis facilities is forecast to maintain robust growth through 2030, underpinned by regulatory requirements, technological advancements, and increasing global trade in food commodities. The next few years are likely to see sustained investments in both high-throughput central laboratories and innovative point-of-need testing solutions, reinforcing the sector’s pivotal role in global food safety assurance.
Emerging Technologies Revolutionizing Aflatoxin Detection
Aflatoxin analysis facilities are experiencing a significant transformation as emerging technologies reshape detection capabilities and operational workflows. In 2025, laboratories worldwide are integrating advanced instrumentation, automation, and digital connectivity to meet evolving regulatory standards and address the growing demand for rapid, accurate mycotoxin screening.
A major trend is the adoption of high-throughput liquid chromatography-tandem mass spectrometry (LC-MS/MS) platforms, which enable simultaneous quantification of multiple mycotoxins, including aflatoxins, with improved sensitivity and specificity. Leading manufacturers such as Thermo Fisher Scientific, Scilogex, and SciLabware are supplying modular LC-MS/MS systems tailored for food safety laboratories, complemented by proprietary software for automated data analysis and compliance reporting.
Automation is another key driver in 2025. Facilities are increasingly deploying robotic liquid handlers and sample preparation systems to streamline workflows and reduce human error. PerkinElmer and Agilent Technologies have developed integrated solutions combining automated extraction, purification, and analytical modules, enabling labs to process hundreds of samples daily while maintaining traceability and reproducibility.
Rapid screening technologies are also gaining momentum. Lateral flow immunoassays and portable fluorescence readers, such as those from Neogen and Romer Labs, are being deployed both in laboratory settings and in-field, enabling near real-time aflatoxin detection in supply chains. These point-of-need devices are facilitating greater surveillance in developing regions, contributing to food safety initiatives and regulatory compliance.
Digital transformation is further enhancing facility capabilities. Laboratory Information Management Systems (LIMS) from providers like LIMSpec are being integrated with analytical instruments and cloud platforms, allowing remote monitoring, secure data sharing, and predictive maintenance scheduling. This connectivity is critical as facilities scale up and seek to harmonize testing procedures across multiple sites.
Looking ahead, aflatoxin analysis facilities are expected to leverage advances in artificial intelligence for data interpretation and anomaly detection, while continued miniaturization of analytical devices may enable even broader deployment in resource-limited settings. Given increasing scrutiny from food safety authorities and expanding global trade, investment in these emerging technologies is poised to accelerate through the late 2020s, ensuring aflatoxin testing remains robust, efficient, and globally accessible.
Major Facility Expansions and New Entrants
The aflatoxin analysis sector is experiencing notable facility expansions and the entrance of new players as global concerns over food safety and regulatory compliance intensify in 2025. Increasing stringency in aflatoxin limits—particularly in the European Union, United States, and emerging markets—continues to drive investment in laboratory infrastructure, rapid testing capabilities, and geographic reach.
- In early 2025, Eurofins Scientific announced the expansion of its food testing laboratories in Eastern Europe and Southeast Asia, equipped with enhanced aflatoxin detection technologies. This move aims to address rising export demands and the region’s vulnerability to aflatoxin contamination in staple crops.
- SGS, a global leader in testing and certification, is increasing its aflatoxin analysis throughput by investing in automated immunoassay and LC-MS/MS systems at its North American and South Asian laboratories. These upgrades are projected to reduce turnaround times for high-volume grain exporters and processors.
- In 2025, Intertek Group plc is establishing new aflatoxin screening facilities in West Africa, targeting cocoa and groundnut supply chains. These laboratories are designed to support local producers in meeting international export standards and to minimize economic losses from contaminated batches.
- Romer Labs continues to expand its global laboratory network, focusing on rapid and on-site aflatoxin detection tools. In 2025, the company is rolling out mobile testing units in Latin America, supporting remote agricultural communities during peak harvest periods.
- New entrants are also capitalizing on technological advances. Start-ups specializing in portable biosensor platforms, such as Neogen Corporation, are launching decentralized testing hubs in partnership with large agro-processors, enhancing traceability and real-time monitoring capabilities.
Outlook for the next few years remains robust, with anticipated growth in facility numbers and capacity, especially in regions facing climate-driven increases in aflatoxin risk. Industry leaders project further integration of digital data platforms, remote diagnostics, and AI-driven analytics to streamline testing workflows and ensure rapid compliance with evolving global standards.
Regulatory Developments: 2025 and Beyond
The regulatory landscape for aflatoxin analysis facilities is evolving rapidly as governments and industry bodies intensify efforts to safeguard food safety and public health. In 2025, several important regulatory events are shaping the operational standards and technological requirements for facilities conducting aflatoxin testing in food and agricultural commodities.
A key development is the ongoing harmonization of aflatoxin testing standards across regions. The U.S. Food and Drug Administration (FDA) continues to enforce stringent aflatoxin limits in domestic and imported foods, recently updating guidance on analytical methods and sample preparation. In parallel, the European Union, via the European Food Safety Authority (EFSA), is reviewing maximum residue limits (MRLs) for aflatoxins and may introduce more rigorous monitoring requirements by 2026, reflecting advancements in detection capabilities.
Increased cross-border trade and global supply chains have prompted organizations such as the International Organization for Standardization (ISO) to accelerate work on uniform aflatoxin testing protocols. The recent release of ISO 16050 updates—specifying improved sampling and analytical procedures—sets a new benchmark for laboratories worldwide, with widespread adoption expected through 2025 and beyond.
Emerging economies are also stepping up. For instance, the Kenya Plant Health Inspectorate Service (KEPHIS) has announced plans to expand laboratory capacity and upgrade testing infrastructure, aiming for compliance with international standards as the nation seeks greater access to export markets. Similar initiatives are underway in India, where the Food Safety and Standards Authority of India (FSSAI) is collaborating with accredited testing facilities to implement mandatory aflatoxin screening for key staples.
Looking forward, the regulatory outlook suggests further tightening of permissible aflatoxin levels and an emphasis on rapid, high-throughput analytical technologies. Instrument manufacturers such as PerkinElmer and Agilent Technologies are responding by introducing automated LC-MS/MS platforms and validated immunoassay kits tailored to meet evolving compliance requirements. These advances support not only regulatory adherence but also the growing demand for transparency and traceability in the global food supply chain.
Overall, as aflatoxin regulations become more robust and harmonized, analysis facilities must adapt through continual investment in technology, staff training, and quality assurance to remain compliant and competitive over the next several years.
Competitive Landscape: Leading Companies & Innovations
The global aflatoxin analysis sector is witnessing strong competitive activity, driven by tightening food safety regulations and heightened demand for reliable contamination detection. In 2025, leading companies are expanding their analytical capabilities and introducing innovations to meet the evolving needs of food producers, processors, and regulatory bodies.
Key players in the aflatoxin analysis facility market include Eurofins Scientific, SGS, Bureau Veritas, and Intertek Group. These organizations operate extensive laboratory networks equipped with advanced instrumentation, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) and immunoassay platforms. Their facilities enable high-throughput, multi-mycotoxin screening, supporting the food supply chain’s compliance with international safety standards.
- Eurofins Scientific has recently invested in expanding its global network of mycotoxin testing laboratories, especially in high-risk regions such as Africa and Asia. The company emphasizes rapid turnaround times and the integration of digital client portals for real-time results access, enhancing traceability and transparency for stakeholders (Eurofins Scientific).
- SGS offers comprehensive aflatoxin analysis services, including accredited methods aligned with the latest Codex Alimentarius and EU regulatory limits. In 2024–2025, SGS has continued to upgrade its laboratories with state-of-the-art automation and robotics, reducing manual errors and increasing sample throughput (SGS).
- Bureau Veritas has expanded its mycotoxin testing reach through strategic acquisitions and new lab openings, focusing on emerging markets and offering tailored solutions for local agricultural commodities. The company’s laboratories support on-site rapid testing as well as central lab confirmatory analysis (Bureau Veritas).
- Intertek Group leverages its global scale to provide end-to-end aflatoxin testing, including risk assessment and audit services. Their investment in digital data management platforms is improving result reporting and enabling data-driven trend analysis for clients (Intertek Group).
Looking ahead, the competitive landscape is expected to intensify as new technologies—such as portable biosensors and AI-powered analytical platforms—enter the market. Leading aflatoxin analysis facilities are likely to further invest in automation, connectivity, and method validation to secure regulatory trust and meet the increasing demands for accurate, rapid, and scalable mycotoxin testing worldwide.
Application Trends: Food, Feed, and Agricultural Sectors
In 2025, aflatoxin analysis facilities are experiencing significant evolution, driven by tightening regulatory scrutiny and heightened awareness of food safety in the food, feed, and agricultural sectors. Globally, aflatoxin contamination remains a persistent challenge, particularly in crops like maize, peanuts, and tree nuts, which are staples in both human and animal diets. The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) continue to highlight the impact of aflatoxins on health and trade, prompting investments in advanced analytical infrastructure.
State-of-the-art aflatoxin analysis laboratories are being established or upgraded within major exporting and processing regions. Facilities increasingly adopt high-throughput technologies, such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) and enzyme-linked immunosorbent assays (ELISA), to improve detection sensitivity and turnaround times. Companies including Eurofins Scientific and SGS have expanded their global laboratory networks, integrating rapid screening solutions for routine monitoring of aflatoxins in cereals, nuts, spices, dairy, and feed matrices.
In the agricultural sector, mobile and on-site analysis capabilities are gaining traction. Portable instruments and lateral flow devices, offered by suppliers like Romer Labs and Neogen Corporation, enable producers and grain elevators to conduct preliminary aflatoxin screening at harvest and storage points, reducing the risk of contaminated batches entering the supply chain. This trend aligns with the increasing demand for real-time data and traceability.
Feed manufacturers are also prioritizing in-house aflatoxin testing, particularly in regions with rising regulatory enforcement such as Europe, North America, and parts of Asia. According to Bühler Group, integrated rapid test labs are now common in large feed mills, supporting compliance, quality assurance, and export certification.
Looking ahead, the next few years are set to witness broader adoption of digital laboratory management systems, automated sample preparation, and data integration platforms. These innovations are expected to streamline aflatoxin monitoring, enhance traceability, and support predictive risk analytics. Collaborative efforts between government agencies, industry stakeholders, and technology providers will likely accelerate the global harmonization of aflatoxin testing standards and facilitate safer, more transparent food and feed supply chains.
Supply Chain Challenges & Solutions
In 2025, the supply chain for aflatoxin analysis facilities is navigating a complex landscape shaped by rising global demand for food safety testing, evolving regulatory requirements, and persistent logistical disruptions. Aflatoxins, toxic metabolites produced by certain molds, continue to pose significant risks to food and feed safety, prompting both developed and developing regions to enhance their analytical capabilities.
One of the primary supply chain challenges is the procurement of high-quality analytical instruments and certified reference materials. Leading manufacturers such as Agilent Technologies and Thermo Fisher Scientific report increased orders for liquid chromatography and mass spectrometry systems tailored for mycotoxin detection. However, fluctuations in supply of electronic components and specialized consumables have occasionally delayed equipment delivery schedules into 2025, reflecting lingering impacts from global semiconductor shortages.
Another bottleneck arises in the sourcing and distribution of certified aflatoxin standards and quality control materials, essential for accurate and reproducible laboratory results. Suppliers like MilliporeSigma are expanding their production capacity and optimizing logistics networks to ensure timely delivery, yet transport disruptions and customs clearance delays—particularly for cross-border shipments—remain hurdles in regions with limited infrastructure.
In response to these challenges, facilities are increasingly adopting digital supply chain management tools and remote calibration services. Companies such as PerkinElmer are enhancing customer support through virtual instrument diagnostics and cloud-based inventory tracking, minimizing downtime and facilitating more accurate forecasting of reagent and consumable needs. Additionally, automation and miniaturization of aflatoxin assays, as seen in the portfolio of Neogen Corporation, are helping laboratories streamline workflow and reduce dependency on large inventories of perishable reagents.
Looking ahead, the integration of rapid screening technologies and portable testing devices is expected to further decentralize aflatoxin analysis, enabling on-site testing at critical control points in the supply chain. Initiatives to harmonize regulatory standards—such as those coordinated by the International Organization for Standardization (ISO)—promise to facilitate cross-border trade and improve supply chain resilience. As investment continues in both laboratory infrastructure and logistics, the sector is poised for improved responsiveness, greater analytical throughput, and enhanced food safety assurance over the next few years.
Sustainability and Automation in Facility Operations
Sustainability and automation are becoming central to the evolution of aflatoxin analysis facilities as the industry responds to growing regulatory demands, cost pressures, and environmental concerns. In 2025, facilities are increasingly integrating advanced automation technologies to enhance throughput, accuracy, and resource efficiency. For example, high-throughput sample preparation systems and robotic liquid handlers are now standard in leading laboratories, allowing for the processing of hundreds of samples daily with minimal human intervention. Instrument manufacturers such as PerkinElmer and Agilent Technologies have introduced automated aflatoxin analysis platforms that combine immunoaffinity cleanup, liquid chromatography, and mass spectrometry, significantly reducing energy use and solvent waste compared to manual workflows.
On the sustainability front, facilities are adopting green chemistry principles and energy-efficient equipment. For instance, Thermo Fisher Scientific and Waters Corporation have developed analytical systems with reduced solvent consumption and lower power requirements, aligning with industry targets to cut laboratory carbon footprints. Some European facilities are piloting closed-loop solvent recycling and on-site renewable energy integration to further reduce environmental impact.
Waste management is also under scrutiny. Laboratories are partnering with certified hazardous waste handlers to ensure proper disposal of aflatoxin-contaminated materials, while also exploring biodegradable alternatives for consumables like pipette tips and sample vials. Organizations such as Eurofins Scientific are publishing annual sustainability reports documenting reductions in hazardous waste generation and progress towards net-zero goals.
Looking to the next few years, regulatory bodies and industry groups are expected to further incentivize sustainable practices through green lab certification programs and procurement guidelines favoring eco-friendly analytical technologies. Automation is poised to deepen, with artificial intelligence (AI) and machine learning increasingly used for data analysis, predictive maintenance, and process optimization—minimizing downtime and energy use. Industry collaborations, such as those coordinated by ICC (International Association for Cereal Science and Technology), are driving standardization of automated, sustainable protocols for aflatoxin detection, ensuring reproducibility and compliance across global supply chains.
Collectively, these trends position aflatoxin analysis facilities to achieve higher operational efficiency, lower environmental impact, and enhanced regulatory compliance from 2025 onward.
Future Outlook: Opportunities and Strategic Recommendations
As global food safety regulations tighten and consumer demand for transparency increases, the outlook for aflatoxin analysis facilities in 2025 and the following years is characterized by both significant opportunities and emerging challenges. Regulatory bodies worldwide are expected to expand the scope of aflatoxin monitoring, particularly in high-risk commodities such as nuts, maize, spices, and dairy products. In response, analysis facilities are poised to invest in advanced detection technologies, automation, and data integration.
Recent years have witnessed rapid adoption of high-throughput analytical techniques, including liquid chromatography-tandem mass spectrometry (LC-MS/MS) and immunoassay-based rapid tests. Leading suppliers, such as Eurofins Scientific and SGS, have expanded their laboratory networks and introduced faster, multi-mycotoxin screening services. These capabilities are increasingly essential as food supply chains globalize and the risks of cross-border contamination rise.
In 2025, facilities are expected to integrate digital platforms for sample tracking, real-time data sharing, and secure client reporting. Companies like R-Biopharm AG and Neogen Corporation are also developing user-friendly, portable kits and semi-automated systems, enabling on-site and near-line aflatoxin detection, which is anticipated to be a strong growth area—especially for regions with limited laboratory infrastructure.
Strategically, analysis facilities should consider the following recommendations for future readiness:
- Invest in multi-mycotoxin platforms: With regulatory limits evolving, facilities equipped to simultaneously analyze multiple mycotoxins—including aflatoxins—will be better positioned for compliance and client demand (Eurofins Scientific).
- Expand digital integration: Adoption of laboratory information management systems (LIMS) and automated data workflows supports traceability, accuracy, and rapid reporting (SGS).
- Strengthen stakeholder partnerships: Collaboration with industry, regulators, and technology providers accelerates method validation and adoption of new detection solutions (R-Biopharm AG).
- Prioritize training and capacity building: Continuous upskilling of laboratory personnel is critical as analytical complexity increases and new test formats are introduced (Neogen Corporation).
Looking ahead, the aflatoxin analysis sector is expected to grow not only in scale but also in sophistication, with a clear trend toward rapid, decentralized, and data-driven testing. Facilities that embrace technological innovation, cross-sector collaboration, and proactive regulatory alignment will be well-positioned to capitalize on expanding opportunities through 2025 and beyond.
